Sandeep Gurbuxani to Multiple Myeloma
This is a "connection" page, showing publications Sandeep Gurbuxani has written about Multiple Myeloma.
Connection Strength
0.434
-
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study. JAMA Oncol. 2022 09 01; 8(9):1278-1286.
Score: 0.165
-
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma. Blood. 2020 11 26; 136(22):2513-2523.
Score: 0.146
-
A Herald of Plasma Cell Myeloma: A Report of Malignant Plasma Cells Identified in Parathyroid Adenoma and a Review of Non-parathyroid Malignancies in Parathyroid Glands. Head Neck Pathol. 2018 Jun; 12(2):286-290.
Score: 0.117
-
MDR1/P-glycoprotein in haematological neoplasms. Eur J Cancer. 1996 Jun; 32A(6):1034-8.
Score: 0.007